| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $129.0M | — |
| R&D Expense | $99.9M | +50.0% |
| SG&A Expense | $32.3M | +5.4% |
| Operating Income | -$3.2M | +96.7% |
| Income Tax | $18.7M | — |
| Net Income | -$6.7M | +92.9% |
| EPS (Basic) | -$0.20 | +93.4% |
| EPS (Diluted) | -$0.20 | +93.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.6M | +49.7% |
| Current Assets | $369.8M | +76.2% |
| Total Assets | $469.2M | +86.1% |
| Current Liabilities | $158.8M | +622.7% |
| Total Liabilities | $226.8M | +474.2% |
| Stockholders' Equity | $242.4M | +14.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $139.8M | +249.1% |
| Capital Expenditures | $5.6M | +94.5% |
| Investing Cash Flow | -$138.4M | +6.9% |
| Financing Cash Flow | $21.0M | +4291.9% |
| Free Cash Flow | $134.2M | +238.8% |